BIOXCEL THERAPEUTICS INC (BTAI) Institutional Ownership Changes & 13F Activity
BIOXCEL THERAPEUTICS INC (BTAI). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Oaktree Capital Management, Vanguard Capital Management Llc, Oaktree Fund Advisors, Llc, Millennium Management Llc, and Citadel Advisors Llc.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Buy | +149,220 | — | 149,220 | $210.40K | Q2 2026 | Sep 02, 2026 |
| Beacon Pointe Advisors, Llc | Sell | -40 | -0.2% | 18,837 | $26.56K | Q2 2026 | Aug 18, 2026 |
| Oaktree Capital Management | Buy | +1,139,060 | +472.3% | 1,380,248 | $1.95M | Q2 2026 | Aug 14, 2026 |
| Oaktree Fund Advisors, Llc | Buy | +202,672 | +472.3% | 245,585 | $346.27K | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Buy | +177,950 | +9.2% | 2,114,710 | $2.98M | Q2 2026 | Aug 14, 2026 |
| Jones Financial Companies Lllp | Sell | -68,650 | -52.1% | 63,139 | $82.71K | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Buy | +17,200 | — | 17,200 | $24.25K | Q2 2026 | Aug 14, 2026 |
| Two Sigma Securities, Llc | Buy | +10,796 | — | 10,796 | $15.22K | Q2 2026 | Aug 14, 2026 |
| &Partners | Buy | +2,724 | +3.4% | 83,588 | $117.86K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Buy | +1,428 | — | 1,428 | $2.01K | Q2 2026 | Aug 14, 2026 |
| Wells Fargo & Company/Mn | Buy | +18 | +0.4% | 4,337 | $6.12K | Q2 2026 | Aug 14, 2026 |
| Vanguard Capital Management Llc | Buy | +712,206 | +343.5% | 919,545 | $1.30M | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Buy | +105,277 | +199.4% | 158,065 | $222.87K | Q2 2026 | Aug 13, 2026 |
| Vanguard Fiduciary Trust Co | Buy | +52,016 | +61.3% | 136,937 | $193.08K | Q2 2026 | Aug 13, 2026 |
| Headlands Technologies Llc | Buy | +25,556 | — | 25,556 | $36.03K | Q2 2026 | Aug 13, 2026 |
| Northern Trust Corp | Buy | +20,005 | +55.1% | 56,318 | $79.41K | Q2 2026 | Aug 13, 2026 |
| Virtu Financial Llc | Buy | +15,967 | — | 15,967 | $23.00K | Q2 2026 | Aug 13, 2026 |
| Morgan Stanley | Sell | -8,917 | -84.2% | 1,671 | $2.36K | Q2 2026 | Aug 13, 2026 |
| Bnp Paribas Financial Markets | Sell | -47 | -79.7% | 12 | $17.00 | Q2 2026 | Aug 13, 2026 |
| Silver Grove Financial Group, Inc. | Sell | -3 | -0.9% | 331 | $468.00 | Q2 2026 | Aug 13, 2026 |
| Stonex Group Inc. | Buy | +20,684 | — | 20,684 | $29.16K | Q2 2026 | Aug 12, 2026 |
| Geode Capital Management, Llc | Buy | +12,083 | +5.2% | 242,251 | $341.91K | Q2 2026 | Aug 12, 2026 |
| Newedge Advisors, Llc | Buy | +1,331 | — | 1,331 | $1.88K | Q2 2026 | Aug 12, 2026 |
| Jpmorgan Chase & Co | Buy | +45 | — | 45 | $63.00 | Q2 2026 | Aug 12, 2026 |
| Tower Research Capital Llc (Trc) | Sell | -1,491 | -86.8% | 227 | $320.00 | Q2 2026 | Aug 11, 2026 |
| Diversify Advisory Services, Llc | Buy | +15,000 | — | 15,000 | $13.01K | Q2 2026 | Aug 10, 2026 |
| Portfolio Strategies, Inc. | Buy | +4,653 | +38.2% | 16,831 | $23.73K | Q2 2026 | Aug 10, 2026 |
| Blackrock, Inc. | Buy | +95,151 | +112.9% | 179,433 | $253.00K | Q2 2026 | Aug 07, 2026 |
| Quadrature Capital Ltd | Buy | +38,038 | — | 38,038 | $53.63K | Q2 2026 | Aug 07, 2026 |
| Citigroup Inc | Buy | +2,998 | — | 2,998 | $4.23K | Q2 2026 | Aug 03, 2026 |
Frequently asked questions about BTAI activity
Which institutional owners are buying BTAI?
Institutional owners buying BTAI include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in BTAI activity?
"Buy" means an investor increased their reported position in BTAI compared to the prior reporting period. This reflects growing exposure to BIOXCEL THERAPEUTICS INC (BTAI) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in BTAI increasing?
Institutional interest in BTAI can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.